NYSE:JNJPharmaceuticals
Johnson And Johnson News Links Clotting Breakthrough To MedTech Trial Progress
Scientists have identified a genetic cause linked to rare blood clotting events associated with Johnson & Johnson's COVID vaccine.
Johnson & Johnson reported encouraging pilot clinical trial data for its Omnypulse pulsed field ablation catheter.
The company also highlighted ongoing work on medical device technology aimed at improving patient outcomes.
For investors tracking NYSE:JNJ, this combination of vaccine safety research and new device data relates directly to two major parts of the...